Angiopoietins contribute to lung development by regulating pulmonary vascular network formation

Biochemical and Biophysical Research Communications

Volumn 381, Issue 2, 2009, Pages 218-223

  Hato, Tai ^a   Kimura, Yoshishige ^a   Morisada, Tohru ^a   Koh, Gou Young ^b   Miyata, Keishi ^c   Tabata, Mitsuhisa ^c   Kadomatsu, Tsuyoshi ^c   Endo, Motoyoshi ^c   Urano, Takashi ^a   Arai, Fumio ^a   Araki, Kimi ^d   Suda, Toshio ^a   Kobayashi, Koichi ^a   Oike, Yuichi ^a,c,e  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c KUMAMOTO UNIVERSITY   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Angiogenesis; Angiopoietin 1; Bronchopulmonary dysplasia (BPD); Lung development

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; SURFACTANT PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; LUNG ALVEOLUS EPITHELIUM; LUNG BLOOD VESSEL; LUNG DEVELOPMENT; LUNG FUNCTION; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; BRONCHOPULMONARY DYSPLASIA; CELL DIFFERENTIATION; HUMANS; INFANT, NEWBORN; LUNG; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, TIE-2; RECOMBINANT FUSION PROTEINS; VASODILATION;

MUS;

EID: 61849108712     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.02.030     Document Type: Article

References (29)

1. Coalson J.J., Winter V.T., Siler-Khodr T., and Yoder B.A. Neonatal chronic lung disease in extremely immature baboons. Am. J. Respir. Crit. Care Med. 160 (1999) 1333-1346
2. Jakkula M., Le Cras T.D., Gebb S., Hirth K.P., Tuder R.M., Voelkel N.F., and Abman S.H. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am. J. Physiol. Lung Cell Mol. Physiol. 279 (2000) L600-L607
3. Janney C.G., Askin F.B., and Kuhn III C. Congenital alveolar capillary dysplasia - an unusual cause of respiratory distress in the newborn. Am. J. Clin. Pathol. 76 (1981) 722-727
4. Kasahara Y., Tuder R.M., Taraseviciene-Stewart L., Le Cras T.D., Abman S., Hirth P.K., Waltenberger J., and Voelkel N.F. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 106 (2000) 1311-1319
5. Le Cras T.D., Spitzmiller R.E., Albertine K.H., Greenberg J.M., Whitsett J.A., and Akeson A.L. VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L134-L142
6. McGrath-Morrow S.A., Cho C., Zhen L., Hicklin D.J., and Tuder R.M. Vascular endothelial growth factor receptor 2 blockade disrupts postnatal lung development. Am. J. Respir. Cell Mol. Biol. 32 (2005) 420-427
7. Bostrom H., Willetts K., Pekny M., Leveen P., Lindahl P., Hedstrand H., Pekna M., Hellstrom M., Gebre-Medhin S., Schalling M., Nilsson M., Kurland S., Tornell J., Heath J.K., and Betsholtz C. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85 (1996) 863-873
8. DeLisser H.M., Helmke B.P., Cao G., Egan P.M., Taichman D., Fehrenbach M., Zaman A., Cui Z., Mohan G.S., Baldwin H.S., Davies P.F., and Savani R.C. Loss of PECAM-1 function impairs alveolarization. J. Biol. Chem. 281 (2006) 8724-8731
9. Gale N.W., and Yancopoulos G.D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13 (1999) 1055-1066
10. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., Ryan T.E., Bruno J., Radziejewski C., Maisonpierre P.C., and Yancopoulos G.D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87 (1996) 1161-1169
11. Dumont D.J., Yamaguchi T.P., Conlon R.A., Rossant J., and Breitman M.L. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7 (1992) 1471-1480
12. Iwama A., Hamaguchi I., Hashiyama M., Murayama Y., Yasunaga K., and Suda T. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem. Biophys. Res. Commun. 195 (1993) 301-309
13. Partanen J., Armstrong E., Makela T.P., Korhonen J., Sandberg M., Renkonen R., Knuutila S., Huebner K., and Alitalo K. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol. Cell Biol. 12 (1992) 1698-1707
14. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadopoulos N., Daly T.J., Davis S., Sato T.N., and Yancopoulos G.D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
15. Sato T.N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-Maguire M., Gridley T., Wolburg H., Risau W., and Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376 (1995) 70-74
16. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., and Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
17. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., Glazer N., Holash J., McDonald D.M., and Yancopoulos G.D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6 (2000) 460-463
18. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., and McDonald D.M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286 (1999) 2511-2514
19. Thurston G., Wang Q., Baffert F., Rudge J., Papadopoulos N., Jean-Guillaume D., Wiegand S., Yancopoulos G.D., and McDonald D.M. Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period. Development 132 (2005) 3317-3326
20. Lee S.W., Kim W.J., Choi Y.K., Song H.S., Son M.J., Gelman I.H., Kim Y.J., and Kim K.W. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat. Med. 9 (2003) 900-906
21. Uemura A., Ogawa M., Hirashima M., Fujiwara T., Koyama S., Takagi H., Honda Y., Wiegand S.J., Yancopoulos G.D., and Nishikawa S. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J. Clin. Invest. 110 (2002) 1619-1628
22. Cho C.H., Kammerer R.A., Lee H.J., Steinmetz M.O., Ryu Y.S., Lee S.H., Yasunaga K., Kim K.T., Kim I., Choi H.H., Kim W., Kim S.H., Park S.K., Lee G.M., and Koh G.Y. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc. Natl. Acad. Sci. USA 101 (2004) 5547-5552
23. Lee K.S., Lee K.Y., Kim S.R., Park H.S., Park S.J., Min K.H., Cho C.H., Koh G.Y., and Lee Y.C. Blockade of airway inflammation and hyper-responsiveness by an angiopoietin-1 variant, COMP-Ang1. Exp. Mol. Med. 39 (2007) 733-745
24. Kim C.F., Jackson E.L., Woolfenden A.E., Lawrence S., Babar I., Vogel S., Crowley D., Bronson R.T., and Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121 (2005) 823-835
25. Scharpfenecker M., Fiedler U., Reiss Y., and Augustin H.G. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J. Cell Sci. 118 (2005) 771-780
26. Tait C.R., and Jones P.F. Angiopoietins in tumours: the angiogenic switch. J. Pathol. 204 (2004) 1-10
27. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., Ikeda Y., Mak T.W., and Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431 (2004) 997-1002
28. Tothova Z., Kollipara R., Huntly B.J., Lee B.H., Castrillon D.H., Cullen D.E., McDowell E.P., Lazo-Kallanian S., Williams I.R., Sears C., Armstrong S.A., Passegue E., DePinho R.A., and Gilliland D.G. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128 (2007) 325-339
29. Arai F., Hirao A., Ohmura M., Sato H., Matsuoka S., Takubo K., Ito K., Koh G.Y., and Suda T. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118 (2004) 149-161